Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply.

Autor: Preskorn SH; Kansas University School of Medicine-Wichita., Risinger R; BioXcel Therapeutics Inc, New Haven, Connecticut., Kakar R; Segal Trials, Fort Lauderdale, Florida.
Jazyk: angličtina
Zdroj: JAMA [JAMA] 2022 Jul 12; Vol. 328 (2), pp. 214-215.
DOI: 10.1001/jama.2022.8349
Databáze: MEDLINE